Positive and Negative In Vitro Interference of Chinese Medicine Dan Shen in Serum Digoxin Measurement
Open Access
- 1 September 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 116 (3) , 403-408
- https://doi.org/10.1309/3wxe-m27d-8hkg-vqtp
Abstract
Dan Shen, a traditional Chinese medicine used in the management of cardiovascular diseases, is now available without prescription in the United States from Chinese herbal stores. We demonstrated digoxin-like immunoreactivity of Dan Shen in vitro. Because Dan Shen is used to treat cardiovascular disease, we studied potential interference of Dan Shen with serum digoxin measurement. Addition of microliter quantities of Dan Shen extract to digoxin pools prepared from patients receiving digoxin resulted in falsely elevated serum digoxin concentrations (positive interference) as measured by the fluorescence polarization immunoassay for digoxin (Abbott Laboratories, Abbott Park, IL). More interestingly, serum digoxin concentrations were falsely lowered (negative interference) when measured by the microparticle enzyme immunoassay, also marketed by Abbott Laboratories. Taking advantage of poor protein binding of digoxin (25%) and high protein binding of digoxin-like immunoreactive components of Dan Shen, we further demonstrated that the positive and negative interference of Dan Shen in serum digoxin measurement can be eliminated by monitoring the free digoxin concentration.Keywords
This publication has 8 references indexed in Scilit:
- Potential interactions between alternative therapies and warfarinAmerican Journal of Health-System Pharmacy, 2000
- Validity of unbound digoxin measurements by immunoassays in presence of antidote (Digibind®)Clinica Chimica Acta; International Journal of Clinical Chemistry, 1999
- Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations.American Journal of Clinical Pathology, 1999
- Effects of Digoxinlike Immunoreactive Substances and Digoxin FAB Antibodies on the New Digoxin Microparticle Enzyme ImmunoassayTherapeutic Drug Monitoring, 1997
- Estimating Concentrations of Total Digoxin and Digoxin-Like Immunoreactive Substances in Volume-Expanded Patients Being Treated with DigoxinTherapeutic Drug Monitoring, 1996
- Unconventional Medicine in the United States -- Prevalence, Costs, and Patterns of UseNew England Journal of Medicine, 1993
- Protective Effect of Danshen During Myocaredial Ischemia and Reperfusion: An Isolated Rat Heart StudyThe American Journal of Chinese Medicine, 1990
- Isolation and Bioactivity of New TanshinonesJournal of Natural Products, 1987